Study to compare Levobupivacaine heavy & Bupivacaine heavy in spinal anesthesia for below belly button operations.

To compare the efficacy of hyperbaric Levobupivacaine(0.5%) versus hyperbaric Bupivacaine (0.5%) in subarachnoid block for infra umbilical surgeries. - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054293

Enrollment

112

Registered

2023-06-22

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N433- Hydrocele, unspecified Health Condition 2: K409- Unilateral inguinal hernia, without obstruction or gangrene Health Condition 3: S829- Unspecified fracture of lower leg Health Condition 4: N814- Uterovaginal prolapse, unspecified

Interventions

Intervention1: Bupivacaine heavy: 3 ml of Bupivacaine 0.5% in subarachnoid block for infra umbilical surgeries Control Intervention1: Levobupivacaine heavy: 3 ml of Levobupivacaine 0.5% in subarachnoi

Eligibility

Inclusion criteria

Inclusion criteria: Age between 20-65 years ASA grade I and II Patient scheduled for infra umbilical surgeries

Exclusion criteria

Exclusion criteria: Patients not giving consent to participate in the study. Uncooperative patient Patients with respiratory, cardiovascular, renal diseases, obesity. Neurological disease (multiple sclerosis, symptomatic lumbar herniated disc, spinal stenosis) Abnormal coagulopathy Patient with known hypersensitivity to local anaesthetic. Local sepsis or infection

Design outcomes

Primary

Measure	Time frame
Its expected that time of onset of motor block is shorter & lasted longer with bupivacaine 0.5% when compared with levobupivacaine0.5% . Time to achieve highest sensory block is faster in levobupivacaine0.5% compared to bupivacaine 0.5% .Timepoint: 12 HOURS	—

Secondary

Measure	Time frame
Its expected that levobupivacaine heavy is haemodynamically more stable than bupivacaine heavy.Timepoint: 12 hours	—

Countries

India

Contacts

Public ContactDr Jitendra Agrawal

Gajra raja Medical college

drjagrawal9@gmail.com9300009942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026